Recent studies have also shown that IKBKE is overexpressed in glioma [8–10], ovarian cancer [10], prostate cancer [11, 12], non-small cell lung cancer [13, 14], gastric cancer [15] and renal clear cell carcinoma [16]. Here, IKBKE is linked to central nervous system cancer.